| http://purl.uniprot.org/citations/17607502 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/17607502 | http://www.w3.org/2000/01/rdf-schema#comment | "Patients with tetralogy of Fallot (TOF) after total correction usually have residual pulmonary regurgitation resulting in right ventricular (RV) dilatation and dysfunction. This study was performed to evaluate N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting RV dilatation and RV dysfunction in TOF after total correction. Twenty-one patients with TOF after total correction (12 males and 9 females, 12.06 +/-2.54 years old) underwent echocardiography, cardiac magnetic resonance imaging (MRI), and blood sampling for NT-proBNP. Mean time after total correction was 7.59 +/-2.30 years. From cardiac MRI study, mean right ventricular end diastolic volume index (RVEDVi) was 148.36 +/-64.50 ml/m2 and mean right ventricular ejection fraction (RVEF) was 35.50 +/-10.50%. Right ventricular dilatation was considered if RVEDVi was >108 ml/m2 and RV dysfunction was considered if RVEF was <40%. A plasma NT-proBNP level of 115 pg/ml was identified by receiver operating characteristic analysis in predicting RV dilatation and/or dysfunction. At this value, the sensitivity and specificity for predicting RV dilatation, RV dysfunction, and both RV dilatation and dysfunction were 71 and 100%, 71 and 71%, and 83 and 78%, respectively. In conclusion, plasma NT-proBNP level may be helpful in follow-up patients. Plasma NT-proBNP levels >115 pg/ml can be used as a marker in the detection of RV dilatation and dysfunction."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.org/dc/terms/identifier | "doi:10.1007/s00246-006-0170-5"xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Khositseth A."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Attanawanich S."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Khowsathit P."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Lolekha P."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Manop J."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Pornkul R."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/author | "Siripornpitak S."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/date | "2007"xsd:gYear |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/name | "Pediatr Cardiol"xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/pages | "333-338"xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/title | "N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction."xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://purl.uniprot.org/core/volume | "28"xsd:string |
| http://purl.uniprot.org/citations/17607502 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/17607502 |
| http://purl.uniprot.org/citations/17607502 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/17607502 |
| http://purl.uniprot.org/uniprot/#_P16860-mappedCitation-17607502 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/17607502 |
| http://purl.uniprot.org/uniprot/P16860 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/17607502 |